This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2015 Nov;9(11):943-4.

doi: 10.1093/ecco-jcc/jjv146. Epub 2015 Sep 7.

High Anti-Tumour Necrosis Factor Trough Concentrations--Only a Cost Issue or Also Hidden Dangers Ahead?

Niels Vande Casteele¹, Séverine Vermeire²

Affiliations

Affiliations

¹ KU Leuven - University of Leuven, Therapeutic and Diagnostic Antibodies, Leuven, Belgium University of California San Diego, Division of Gastroenterology, La Jolla, CA, USA niels.vandecasteele@kuleuven.be.
² University Hospitals Leuven, Department of Gastroenterology, Leuven, Belgium.

PMID: 26351380
DOI: 10.1093/ecco-jcc/jjv146

Editorial

High Anti-Tumour Necrosis Factor Trough Concentrations--Only a Cost Issue or Also Hidden Dangers Ahead?

Niels Vande Casteele et al. J Crohns Colitis. 2015 Nov.

. 2015 Nov;9(11):943-4.

doi: 10.1093/ecco-jcc/jjv146. Epub 2015 Sep 7.

Authors

Niels Vande Casteele¹, Séverine Vermeire²

Affiliations

¹ KU Leuven - University of Leuven, Therapeutic and Diagnostic Antibodies, Leuven, Belgium University of California San Diego, Division of Gastroenterology, La Jolla, CA, USA niels.vandecasteele@kuleuven.be.
² University Hospitals Leuven, Department of Gastroenterology, Leuven, Belgium.

PMID: 26351380
DOI: 10.1093/ecco-jcc/jjv146

No abstract available

Keywords: Trough levels; arthralgia; paradoxical inflammation; skin lesions.

PubMed Disclaimer

Comment on

Serum Concentration of Anti-TNF Antibodies, Adverse Effects and Quality of Life in Patients with Inflammatory Bowel Disease in Remission on Maintenance Treatment.
Brandse JF, Vos LM, Jansen J, Schakel T, Ponsioen CI, van den Brink GR, D'Haens GR, Löwenberg M. Brandse JF, et al. J Crohns Colitis. 2015 Nov;9(11):973-81. doi: 10.1093/ecco-jcc/jjv116. Epub 2015 Jun 26. J Crohns Colitis. 2015. PMID: 26116557 Clinical Trial.
Association Between Infliximab Trough Levels and the Occurrence of Paradoxical Manifestations in Patients with Inflammatory Bowel Disease: a Case-Control Study.
Coutzac C, Chapuis J, Poullenot F, Chabrun E, Capdepont M, Blanco P, Laharie D. Coutzac C, et al. J Crohns Colitis. 2015 Nov;9(11):982-7. doi: 10.1093/ecco-jcc/jjv159. Epub 2015 Sep 7. J Crohns Colitis. 2015. PMID: 26351388 Clinical Trial.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Medical
- MedlinePlus Health Information